Algorae Pharmaceuticals Limited (ASX:1AI)

Algorae Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	-	-	-	0	0.27
Revenue Growth (YoY)	-	-	-	-98.73%	-51.56%
Gross Profit	-	-	-	0	0.27
Selling, General & Admin	0.18	0.2	0.21	-	-
Research & Development	0.85	0.74	1.31	1.46	1.61
Operating Expenses	1.07	1.7	1.52	1.46	1.61
Operating Income	-1.07	-1.7	-1.52	-1.46	-1.34
Interest Expense	-0	-	-	-	-
Interest & Investment Income	0.14	0.13	0.04	-	-
Currency Exchange Gain (Loss)	0.02	-0.02	-0.02	0.01	-0
Other Non Operating Income (Expenses)	-0.63	-0.5	-0.61	-0.91	-0.67
EBT Excluding Unusual Items	-1.54	-2.09	-2.11	-2.36	-2.01
Gain (Loss) on Sale of Investments	-	-	-	-	0.11
Gain (Loss) on Sale of Assets	-	-0	-	-0.01	-
Pretax Income	-1.54	-2.1	-2.11	-2.37	-1.91
Income Tax Expense	-0.74	-	-	-0.41	-0.44
Net Income	-0.8	-2.1	-2.11	-1.96	-1.46
Net Income to Common	-0.8	-2.1	-2.11	-1.96	-1.46
Shares Outstanding (Basic)	1,687	1,663	1,347	876	571
Shares Outstanding (Diluted)	1,687	1,663	1,347	876	571
Shares Change (YoY)	1.46%	23.47%	53.82%	53.24%	-
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.79	-1.52	-1.99	-2.05	-1.46
Free Cash Flow Per Share	-	-0.00	-0.00	-0.00	-0.00
Gross Margin	-	-	-	100.00%	100.00%
Operating Margin	-	-	-	-42870.16%	-500.05%
Profit Margin	-	-	-	-57483.11%	-544.62%
Free Cash Flow Margin	-	-	-	-60088.31%	-544.97%
EBITDA	-	-1.7	-1.52	-1.46	-1.34
D&A For EBITDA	-	0	0	0	0
EBIT	-1.07	-1.7	-1.52	-1.46	-1.34

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.